SLU-PP-332 10mg

Research

Scientific Applications of SLU-PP-332 in Research

SLU-PP-332 is a small synthetic molecule developed to act as a pan-ERR agonist, interacting with all three estrogen-related receptors: ERRα, ERRβ, and ERRγ. These nuclear receptors play a central role in regulating genes associated with energy metabolism, mitochondrial function, and cellular metabolic adaptation.

By modulating metabolic pathways broadly involved in energy homeostasis, SLU-PP-332 has been extensively investigated in preclinical models focused on muscular, cardiac, and systemic metabolism.

Interaction with ERR Receptors and Transcriptional Activation

Biochemical studies demonstrate that SLU-PP-332 exhibits differential functional affinity among ERR subtypes, with higher relative potency for ERRα, followed by ERRβ and ERRγ. Binding occurs directly at the ligand-binding domain of these nuclear receptors.

Structural modeling indicates that aromatic portions of the molecule establish π–π stacking interactions with specific residues within the ERR active site, stabilizing the receptor’s active conformation. Once activated, ERRs recognize ERR response elements (ERREs) located in promoter regions of DNA, increasing transcriptional activity of genes involved in:
• Mitochondrial biogenesis
• Energy substrate oxidation
• Cellular oxidative metabolism

Applications in Skeletal Muscle Research

In skeletal muscle cell models, such as C2C12 myoblasts, exposure to SLU-PP-332 results in increased maximal mitochondrial respiratory capacity and stimulation of mitochondrial biogenesis.

Morphological and molecular analyses indicate:
• Increased mitochondrial density
• Elevated mitochondrial DNA copy number
• Higher expression of oxidative phosphorylation proteins

The activity of oxidative enzymes, such as succinate dehydrogenase (SDH), is also increased, reflecting enhanced oxidative capacity in experimental muscle tissue models.

Activation of Exercise-Associated Gene Programs

Transcriptomic studies reveal that SLU-PP-332 induces a gene expression profile similar to that observed after acute aerobic exercise in both animal and human models.

Among regulated genes, DDIT4 stands out, showing transient upregulation, peaking within a few hours and subsequently returning to baseline levels. This pattern mimics physiological responses to exercise and is associated with modulation of the mTOR pathway, which is essential for metabolic adaptation to energy stress.

Other regulated genes include mitochondrial transporters, circadian regulators, and transcription factors involved in energy metabolism, reinforcing the use of SLU-PP-332 as an experimental tool in exercise biology research.

Tissue-Specific Dependence of ERR Isoforms

The metabolic effects of SLU-PP-332 exhibit isoform-specific dependence depending on the tissue analyzed:
• Skeletal muscle: predominantly mediated by ERRα
• Cardiac tissue: greater functional dependence on ERRγ

Genetic models with specific ERR deletions confirm that the absence of these isoforms significantly reduces or abolishes the transcriptional response to the compound, highlighting its context-dependent functional selectivity.

Cardiac Metabolism and Mitochondrial Function

In cardiac tissue, activation of ERRγ by SLU-PP-332 is associated with upregulation of genes involved in:
• Fatty acid oxidation
• Tricarboxylic acid (TCA) cycle
• Electron transport chain

Functional assays demonstrate preserved mitochondrial respiration and increased oxidative capacity in cultured cardiomyocytes, including enhanced utilization of fatty acids as an energy substrate.

Investigated Systemic Metabolic Effects

In animal models, metabolic analyses indicate that SLU-PP-332 promotes a shift in substrate utilization, favoring lipid oxidation over carbohydrate metabolism.

This adaptation occurs without significant changes in food intake or locomotor activity, suggesting an increase in basal energy expenditure similar to that observed during post-exercise recovery periods.

Mitochondrial Biogenesis and Chronic Adaptation

Repeated administration of SLU-PP-332 in experimental models leads to a sustained increase in mitochondrial content in skeletal muscle. A phenotypic shift in muscle fibers toward more oxidative profiles is also observed, associated with greater metabolic efficiency.

Unlike genes transiently induced by acute exercise, structural and enzymatic mitochondrial genes remain elevated during chronic experimental protocols.

Structural Considerations and Molecular Selectivity

SLU-PP-332 was developed through structural modifications of previously described ERR agonists, specifically optimized to enhance interaction with ERRα. These modifications resulted in increased potency and functional selectivity.

Selectivity assays indicate no significant activity on classical estrogen receptors (ERα and ERβ), nor on other nuclear receptors or G protein-coupled receptors evaluated.

Cellular Stress Response and Autophagy

In cardiomyocytes, SLU-PP-332 induces changes consistent with moderate activation of autophagy, including alterations in markers associated with autophagic flux. Regulation of DDIT4 contributes to temporary suppression of the mTOR pathway, favoring metabolic adaptation and cellular remodeling processes.

Final Considerations

SLU-PP-332 represents a valuable experimental tool for investigating transcriptional programs mediated by ERR receptors. Its isoform- and tissue-dependent activity enables controlled exploration of molecular mechanisms regulating energy metabolism, mitochondrial function, and exercise-like adaptations.

Its use remains restricted to scientific research, requiring strict adherence to appropriate experimental protocols and applicable regulatory standards.

References
Billon C, Sitaula S, Banerjee S, Welch R, Elgendy B, Hegazy L, et al. (2023). A synthetic ERRα/β/γ agonist induces an acute aerobic exercise-like response. American Chemical Society (ACS). https://doi.org/10.1021/acschembio.2c00720
Zhidkova EM, Lylova ES, Grigoreva DD, et al. (2022). Nutrient sensor REDD1 in cancer and inflammation. MDPI AG. https://doi.org/10.3390/ijms23179686
Xu W, Billon C, Li H, et al. (2024). Novel pan-ERR agonists improve heart failure by enhancing cardiac fatty acid metabolism. Ovid Technologies. https://doi.org/10.1161/circulationaha.123.066542
Billon C, Schoepke E, Avdagic A, et al. (2024). A synthetic ERR agonist alleviates metabolic syndrome. Elsevier BV. https://doi.org/10.1124/jpet.123.001733

Scientific Reviewer
This content was reviewed by Dr. Ky H. Le, MD. Dr. Ky H. Le is a family medicine physician in Aiea, Hawaii. He earned his medical degree from St. George’s University School of Medicine and has over 20 years of clinical experience. His expertise includes obesity, diabetes, hypertension, and related conditions. He accepts Medicare, Aetna, Humana, Blue Cross, and United Healthcare.
Ref.: https://health.usnews.com/doctors/ky-le-371599#expertise